P

Inventor

WRIGHT STEPHEN

US78 patents
⚠️ This page may combine multiple inventors who share the name “WRIGHT STEPHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GW RES LTD

22 patents
US11701330B2Jul 18, 2023

Use of cannabinoids in the treatment of epilepsy

GW RES LTD19 citations98
US11633369B2Apr 25, 2023

Use of cannabinoids in the treatment of epilepsy

GW RES LTD26 citations98
US11446258B2Sep 20, 2022

Use of cannabinoids in the treatment of epilepsy

GW RES LTD30 citations98
US11154516B2Oct 26, 2021

Use of cannabinoids in the treatment of epilepsy

GW RES LTD42 citations98
US11154517B2Oct 26, 2021

Use of cannabinoids in the treatment of epilepsy

GW RES LTD38 citations98
US11096905B2Aug 24, 2021

Use of cannabinoids in the treatment of epilepsy

GW RES LTD43 citations98
US10966939B2Apr 6, 2021

Use of cannabinoids in the treatment of epilepsy

GW RES LTD47 citations98
US10849860B2Dec 1, 2020

Use of cannabinoids in the treatment of epilepsy

GW RES LTD49 citations98
US10709671B2Jul 14, 2020

Use of cannabinoids in the treatment of epilepsy

GW RES LTD52 citations98
US10709674B2Jul 14, 2020

Use of cannabinoids in the treatment of epilepsy

GW RES LTD50 citations98
US10603288B2Mar 31, 2020

Use of cannabinoids in the treatment of epilepsy

GW RES LTD49 citations98
US11065209B2Jul 20, 2021

Use of cannabidiol in the treatment of epilepsy

GW RES LTD43 citations97
US10918608B2Feb 16, 2021

Use of cannabidiol in the treatment of epilepsy

GW RES LTD50 citations97
US11963937B2Apr 23, 2024

Use of cannabinoids in the treatment of epilepsy

GW RES LTD14 citations95
US11766411B2Sep 26, 2023

Use of cannabinoids in the treatment of epilepsy

GW RES LTD17 citations95
US11357741B2Jun 14, 2022

Use of cannabinoids in the treatment of epilepsy

GW RES LTD33 citations95
US11426362B2Aug 30, 2022

Oral cannabinoid formulations

GW RES LTD27 citations93
US11400055B2Aug 2, 2022

Use of cannabidiol in the treatment of epilepsy

GW RES LTD29 citations93
US11229612B2Jan 25, 2022

Parenteral formulations

GW RES LTD29 citations93
US11679087B2Jun 20, 2023

Use of cannabinoids in the treatment of Angelman syndrome

GW RES LTD18 citations92
US11000486B2May 11, 2021

Combination of cannabinoids in the treatment of leukaemia

GW RES LTD16 citations92
US10583096B2Mar 10, 2020

Use of cannabinoids in the treatment of epilepsy

GW RES LTD35 citations92

GW PHARMA LTD

14 patents
US10137095B2Nov 27, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD63 citations99
US10111840B2Oct 30, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD67 citations99
US10092525B2Oct 9, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD62 citations99
US9956183B2May 1, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD69 citations99
US9956186B2May 1, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD68 citations99
US9956185B2May 1, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD71 citations99
US9956184B2May 1, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD67 citations99
US9949937B2Apr 24, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD64 citations99
US11311498B2Apr 26, 2022

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD34 citations98
US9522123B2Dec 20, 2016

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

GW PHARMA LTD62 citations98
US9949936B2Apr 24, 2018

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD54 citations96
US9474726B2Oct 25, 2016

Use of cannabinoids in the treatment of epilepsy

GW PHARMA LTD74 citations96
US10765643B2Sep 8, 2020

Use of cannabidiol in the treatment of epilepsy

GW PHARMA LTD35 citations94
US9675654B2Jun 13, 2017

Phytocannabinoids in the treatment of cancer

GW PHARMA LTD17 citations89

JAZZ PHARMACEUTICALS RESEARCH UK LTD

3 patents
US12064399B2Aug 20, 2024

Use of cannabinoids in the treatment of epilepsy

JAZZ PHARMACEUTICALS RESEARCH UK LTD14 citations94
US12318356B2Jun 3, 2025

Use of cannabinoids in the treatment of epilepsy

JAZZ PHARMACEUTICALS RESEARCH UK LTD2 citations86
US12064398B2Aug 20, 2024

Parenteral formulations

JAZZ PHARMACEUTICALS RESEARCH UK LTD9 citations84

STC PLC

2 patents
US4781428ANov 1, 1988

Devices and methods for selectively tapping optical energy from an optical fibre

STC PLC28 citations92
US4732447AMar 22, 1988

Homodyne optical coherent receiver for digital optical signals

STC PLC28 citations86

INT STANDARD ELECTRIC CORP

2 patents
US4596052AJun 17, 1986

Coherent optical receiver

INT STANDARD ELECTRIC CORP30 citations92
US4173412ANov 6, 1979

Strain measurement

INT STANDARD ELECTRIC CORP53 citations92

WHALLEY BEN

1 patent
US9066920B2Jun 30, 2015

Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy

WHALLEY BEN74 citations96

SGS THOMSON MICROELECTRONICS

1 patent
US6543000B1Apr 1, 2003

Interrupt management system with timers and controller able to detect the interrupt missed and generate appropriate warning signal for error handling

SGS THOMSON MICROELECTRONICS23 citations93

PAROLARO DANIELA

1 patent
US8790719B2Jul 29, 2014

Phytocannabinoids in the treatment of cancer

PAROLARO DANIELA43 citations91

ERICSSON INC

1 patent
US6105057AAug 15, 2000

Method and apparatus for manipulating mutexes on network assets

ERICSSON INC42 citations89

EXXONMOBIL UPSTREAM RES CO

1 patent
US7526926B2May 5, 2009

Method for efficient nonsynchronous LNG production

EXXONMOBIL UPSTREAM RES CO29 citations88

D F FOREMAN ENTERPRISES LTD

1 patent
US5819482AOct 13, 1998

Structural support column with a telescopically adjustable head

D F FOREMAN ENTERPRISES LTD71 citations88

COMPASS PATHFINDER LTD

1 patent
US11865126B2Jan 9, 2024

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

COMPASS PATHFINDER LTD5 citations82

Showing the top 50 of 78 patents by PatentIndex Score.